To access this element change to forms mode OFF
Grant Award View - GA276516
Muscle-directed gene therapy as an adjuvant to neuroprotection:...
GA ID:
GA276516
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$1,122,472.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Muscle-directed gene therapy as an adjuvant to neuroprotection: Targeting both ends of the dysfunctional nerve-muscle axis to treat motor neurone disease
Purpose:
Amyotrophic lateral sclerosis involves nerve cell death and deterioration of the muscles that the nerves control. Effective treatments are lacking. Capitalising on our team’s complementary expertise in neuroscience and muscle physiology, we are developing a multimodal treatment strategy designed to protect nerves and promote muscle re-growth. Targeting both ends of the ‘nerve-muscle axis’ will prevent premature death of people with this disease and stimulate functional recovery.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2021010
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA